๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer
NCT05341492EGFR/ B7H3-positive Advanced Lung Cancer, EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer
Second Affiliated Hospital of Guangzhou Medical University
Phase EARLY_PHASE1
30
Guangzhou
2022-05-01
Recruiting
Goal-directed LCVP Based on HP in Laparoscopic Hepatectomy
NCT05887661Hepatocellular Carcinoma
The First Affiliated Hospital with Nanjing Medical University
Not applicable
100
Nanjing
2022-05-01
Recruiting
Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors
NCT05189054Stereotactic Body Radiation Therapy, Irradiation; Reaction, Thoracic Tumor, Recurrent Cancer
Peking University Third Hospital
Observational
40
Beijing
2022-05-01
Recruiting
Clinical Characteristics of People With Long-term Type 1 Diabetes
NCT05359796Type 1 Diabetes
Second Xiangya Hospital of Central South University
Observational
400
Changsha
2022-05-01
Recruiting
CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection
NCT05433467Cirrhosis, Liver, Hepatocellular Carcinoma
Northern Jiangsu People's Hospital
Not applicable
5
Yangzhou
2022-05-01
Not yet open
Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA
NCT04698330Type 1 Diabetes Mellitus, Autoimmune Diabetes
Second Xiangya Hospital of Central South University
Phase 4
240
Changsha
2022-05
Recruiting
A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children
NCT04955210Critical Illness, Severe Sepsis
Children's Hospital of Fudan University
Observational
5,000
Shanghai
2022-04-30
Recruiting
Comparison of Conservative and Endovascular Treatment for Spontaneously Isolated Superior Mesenteric Artery Dissection
NCT05342233Spontaneous Isolated Superior Mesenteric Artery Dissection
Xiangya Hospital of Central South University
Observational
200
Changsha
2022-04-30
Not yet open
A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
NCT05367765CML, Chronic Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 4
2,400
Harbin
2022-04-30
Recruiting
Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
NCT06417502Autoimmune Diseases, Autoinflammatory Diseases
Peking Union Medical College Hospital
Observational
20,000
Beijing, Chongqing, Shenzhen, Changsha, Nanjing, Hangzhou
2022-04-29
Recruiting
A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.
NCT05367700CML, Chronic Phase, CML, Accelerated Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
108
Wuhan
2022-04-28
Recruiting
Observational Study About Patients Diagnosed With NAFLD
NCT05625750Nonalcoholic Fatty Liver Disease
Xiangya Hospital of Central South University
Observational
500
Changsha
2022-04-27
Recruiting
Acupuncture vs Sham Acupuncture for Hand Osteoarthritis
NCT05267093Hand Osteoarthritis
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not applicable
340
Beijing
2022-04-26
Recruiting
Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma
NCT05294055Multiple Myeloma, Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
120
Hefei, Beijing, Zhengzhou, Jinan, Tianjin
2022-04-26
Active, closed
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
NCT05171647Non-Hodgkin Lymphoma
Hoffmann-La Roche
Phase 3
208
Chengdu, Fuzhou, Guangzhou, Tianjin, Wuhan, Zhengzhou
2022-04-25
Active, closed
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjetaยฎ in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer
NCT05346224Breast Cancer, Breast Neoplasms, HER2-positive Breast Cancer
Shanghai Henlius Biotech
Phase 3
900
Bengbu, Hefei, Lu'an, Maโ€™anshan, Wuhu, Beijing, Chongqing, Chongqi
2022-04-25
Recruiting
Application of FIT-DNA Detection in Following Colorectal Cancer Resection-Implications for Surveillance
NCT05528783Colorectal Cancer
Sun Yat-sen University
Observational
200
Guangzhou
2022-04-25
Active, closed
SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer
NCT05319574Carcinoma, Non-Small-Cell Lung
Sun Yat-sen University
Phase 2
46
Guangzhou
2022-04-24
Recruiting
Super-Hypofractionated Partial Breast Irradiation
NCT06615466Breast Cancer, Radiotherapy Side Effect
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
50
Beijing
2022-04-22
Recruiting
A Study of CM350 in Patients With Advanced Solid Tumors
NCT05263960Advanced Solid Tumor
Keymed Biosciences Co.Ltd
Phase 1/2
248
Chengdu, Shanghai
2022-04-21
Recruiting
Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma
NCT05248633Solitary Plasmacytoma
Peking Union Medical College Hospital
Phase 2
220
Beijing
2022-04-21
Recruiting
Multiomics Tumor Evolution Model of NSCLC
NCT05352035Non-small Cell Lung Cancer
Peking University People's Hospital
Observational
300
Beijing
2022-04-20
Recruiting
Nituzumab (Taixinsheng ยฎ๏ผ‰ A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma
NCT05508347Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute
Phase 2
170
Chengdu
2022-04-20
By invitation
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab
NCT05303532Cancer
AstraZeneca
Phase 3
214
Beijing, Changsha, Hangzhou, Nanjing, Shanghai, Shenyang, Wenzhou, Xi'an
2022-04-19
Active, closed
Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3
NCT05222906Gaucher's Disease Type III
Sanofi
Phase 3
43
Taipei, Beijing, Guangzhou, Shanghai
2022-04-18
Recruiting
BeijngFH Health Cohort Study
NCT05546086Non-Alcoholic Fatty Liver Disease
Beijing Friendship Hospital
Observational
8,103
Beijing
2022-04-18
Active, closed
A Study of Anti-IL-6R mAb Injection in Patients With iMCD
NCT05345522Idiopathic Multicentric Castleman's Disease
Beijing VDJBio Co., LTD.
Phase 2
25
Beijing, Chengdu
2022-04-18
Recruiting
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
NCT05342792Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
556
Guangzhou
2022-04-17
Recruiting
China Gender-affirming Hormone Therapy Study
NCT05318755Transgender, Gender Incongruence
Peking University Third Hospital
Observational
240
Beijing
2022-04-16
Recruiting
68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients
NCT05324332Prostate Cancer
Peking Union Medical College Hospital
Not applicable
50
Beijing
2022-04-15
Recruiting
Transapical Beating-heart Septal Myectomy in Patient With Hypertrophic Obstructive Cardiomyopathy
NCT05332691Hypertrophic Obstructive Cardiomyopathy
Xiang Wei
Not applicable
1,000
Wuhan
2022-04-15
Recruiting
Chemotherapy Supported by Autologous Hematopoietic Stem Cells
NCT05401162Ovarian Cancer
Chongqing University Cancer Hospital
Not applicable
40
Chongqing
2022-04-15
Recruiting
Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
NCT06706713Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation
BeBetter Med Inc
Phase 2
200
Guangzhou, Changsha
2022-04-15
Recruiting
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
NCT05208047Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer
Cogent Biosciences, Inc.
Phase 3
482
2022-04-14
Recruiting
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation
NCT05288205KRAS P.G12C, Non-small Cell Lung Cancer, Colorectal Cancer, Pancreatic Ductal Carcinoma
Allist Pharmaceuticals, Inc.
Phase 1/2
240
Hefei, Beijing, Fuzhou, Xiamen, Guangzhou, Shenzhen, Harbin, Zhengzhou
2022-04-14
Active, closed
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
NCT05288166Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs
Eli Lilly and Company
Phase 3
925
Bengbu, Hefei, Wuhu, Beijing, Guangzhou, Harbin, Wuhan, Changsha
2022-04-14
By invitation
Study of Brain Function Evaluation and Intervention System for Acute and Prolonged Disorders of Consciousness
NCT05682248Disorder of Consciousness
Xuanwu Hospital, Beijing
Not applicable
180
Beijing
2022-04-13
By invitation
Study of Brain Function Evaluation System for Acute and Prolonged Disorders of Consciousness
NCT06097013Disorder of Consciousness
Xuanwu Hospital, Beijing
Observational
500
Beijing
2022-04-13
Recruiting
Hematopoietic Stem Cell-containing Autologous Blood Reinfusion for Bone Marrow Protection in Cervical Cancer Patients
NCT05401175Cervical Cancer
Chongqing University Cancer Hospital
Not applicable
40
Chongqing
2022-04-13
Recruiting
Modified CV Regimen in Optic Pathway Glioma
NCT05278715Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma
Beijing Sanbo Brain Hospital
Phase 2
75
Beijing
2022-04-13
Recruiting
Urine and Ultrasound Screening for Kidney Disease in Children
NCT06018831Kidney Diseases, Diagnostic Techniques, Ultrasound, Urinalysis
Children's Hospital of Fudan University
Not applicable
13,000
Nantong, Suzhou
2022-04-12
Active, closed
A Study of ILB2109 in Patients With Advanced Solid Malignancies
NCT05278546Advanced Solid Tumor
Innolake Biopharm
Phase 1
48
Jinan, Shanghai
2022-04-11
Recruiting
Chronic Kidney Disease-related Sarcopenia With Poor Prognosis
NCT05353660Chronic Kidney Diseases, Sarcopenia
Nanfang Hospital, Southern Medical University
Observational
1,000
Guangzhou
2022-04-11
Recruiting
Surgery or Chemoradiotherapy for Cervical Esophageal Cancer
NCT05327517Cervical Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
192
Beijing
2022-04-10
Active, closed
An Observational Cohort Study to Obese Patients With Weight Cycling
NCT05311462Weight Cycling, Obesity
Peking Union Medical College Hospital
Observational
180
Beijing
2022-04-08
Recruiting
To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors
NCT0538869519 and 22+ B Cell Hematologic Tumors, 19 and 20+ B Cell Hematologic Tumors
Hebei Senlang Biotechnology Inc., Ltd.
Phase 1
100
Wuhan
2022-04-08
Recruiting
KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy
NCT05427383Stomach Cancer
Shanghai JMT-Bio Inc.
Phase 2/3
286
Beijing
2022-04-07
Recruiting
Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)
NCT05145361NMO Spectrum Disorder
Shanghai Pharmaceuticals Holding Co., Ltd
Phase EARLY_PHASE1
45
Beijing, Taiyuan, Xiโ€™an, Tianjin
2022-04-07
By invitation
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
NCT05248659Immunoglobulin A Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Beijing, Guangzhou, Changsha, Wuxi, Nanchang, Jinan, Chengdu, Yibin
2022-04-05
Active, closed
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)
NCT05239741Colorectal Neoplasms
Merck Sharp & Dohme LLC
Phase 3
100
Beijing, Tianjin, Chongqing, Fuzhou, Guangzhou, Shantou, Nanning, Harbin
2022-04-02
Recruiting
Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors
NCT05758389Head and Neck Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
29
Nanjing
2022-04-01
Recruiting
Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment
NCT06169449Endometrium Cancer
Peking University People's Hospital
Not applicable
240
Beijing
2022-04-01
Recruiting
The Efficacy of Auto-cross Linked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception
NCT05085067Retained Products of Conception
Fu Xing Hospital, Capital Medical University
Not applicable
86
Beijing
2022-04-01
Recruiting
A Community Population Screening Cohort Study Based on Polygene Methylation Detection for Colorectal Cancer in Yangzhou
NCT05336539Colorectal Cancer
Singlera Genomics Inc.
Observational
80,000
Yangzhou
2022-04-01
Recruiting
Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer
NCT05284539Non Small Cell Lung Cancer
Hunan Province Tumor Hospital
Phase 2
760
Changsha
2022-04-01
Recruiting
Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)
NCT06553911Respiratory Infectious Diseases, Artificial Intelligence, Medical Imaging
Huashan Hospital
Not applicable
2,000
Shanghai
2022-04-01
Recruiting
Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ยฑ Silibinin in Treating Newly Diagnosed AML (Non-M3).
NCT07561892Acute Myeloid Leukemia, Newly Diagnosed, Chemotherapy Effect
Fujian Medical University Union Hospital
Phase 4
100
Fuzhou
2022-04-01
Recruiting
A National Registry on Chinese Patients With Cystic Fibrosis
NCT05289245Pulmonary Function
Peking Union Medical College Hospital
Observational
200
Beijing
2022-04-01
Recruiting
Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer
NCT05245474Locally Advanced Rectal Cancer
Beijing Friendship Hospital
Phase 2
186
Beijing
2022-04-01
Recruiting
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
NCT05340491Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
212
Guangzhou, Beijing, Chengdu, Fuzhou, Guiyang, Hangzhou, Nanchang, Nanning
2022-04-01
Recruiting
Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer
NCT05804916Breast Cancer, Optical Surface Monitoring Technology, Large-segment Radiotherapy
Peking Union Medical College Hospital
Phase 2/3
556
Beijing
2022-04-01
Recruiting
Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients
NCT05376111T-cell Acute Lymphoblastic Leukemia, Recruiting
The First Affiliated Hospital of Soochow University
Phase 2
28
Suzhou
2022-04-01
Recruiting
TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma.
NCT05872880Oral Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma
Xiangya Hospital of Central South University
Observational
124
Changsha
2022-04-01
Not yet open
Urinary Continence of Female POPRC and OIN
NCT05325216Urinary Bladder Neoplasms, Woman, Sexual Dysfunction, Physiological, Treatment Outcome
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
58
Guangzhou
2022-04
Not yet open
The Safe Study of Routine Closure of Mesenteric Defects Versus Non-closure After Radical Gastrectomy
NCT05356156Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University
Not applicable
1,968
Nanjing
2022-04
Not yet open
A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors.
NCT05320874Advanced Solid Tumor
Xuanzhu Biopharmaceutical Co., Ltd.
Phase 1
232
Beijing
2022-04
Not yet open
A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)
NCT05181501Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd.
Phase 1
20
Hefei, Changzhou, Nanjing
2022-04
Recruiting
Effect of Dexmedetomidine on Postoperative Delirium After Awake Craniotomies
NCT05195034Dexmedetomidine, Delirium, Awake Craniotomy
Beijing Tiantan Hospital
Not applicable
210
Beijing
2022-03-31
Active, closed
Olorofim Aspergillus Infection Study
NCT05101187Invasive Aspergillosis
F2G Biotech GmbH
Phase 3
225
Bengbu, Wuhan, Nanchang, Jinan, Shanghai, Xiaobailou, Wenzhou, Beijing
2022-03-31
Recruiting
Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer
NCT05525767Solid Tumor
Hebei Medical University Fourth Hospital
Phase 4
75
Shijiazhuang
2022-03-31
Recruiting
National Registry and Cohort Study of Pulmonary Vascular Disease
NCT05368467Pulmonary Arterial Hypertension
Nanjing First Hospital, Nanjing Medical University
Observational
1,000
Guangzhou, Nanjing, Tianjin, Beijing, Changsha, Chendu, Shenyang, Wuhan
2022-03-29
Recruiting
Effect of Remimazolam With Protocolized Sedation on Critical Ill, Mechanical Ventilated Patients Compared With Midazolam
NCT05160987Sedation and Analgesia
Zhujiang Hospital
Not applicable
440
Guangzhou
2022-03-29
Recruiting
Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer
NCT05065957Biliary Tract Cancer
InnoPharmax Inc.
Phase 2/3
180
2022-03-29
Recruiting
A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai
NCT05387304COVID-19
Ruijin Hospital
Observational
250,000
Shanghai
2022-03-29
Recruiting
Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma
NCT05290194Radiotherapy, PD-1 Inhibitor, Capecitabine, Nasopharyngeal Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2
28
Zhuhai
2022-03-28
Active, closed
Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC
NCT05301842Hepatocellular Carcinoma
AstraZeneca
Phase 3
760
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Haikou, Hangzhou
2022-03-28
Active, closed
STOPS Trial: Total vs Subtotal Colectomy for Slow Transit Constipation
NCT05352074Slow Transit Constipation, Surgery
Third Military Medical University
Not applicable
252
Yuzhong, Lanzhou, Wuhan, Nanjing, Shengyang, Qingdao, Pudong, Xiโ€™an
2022-03-27
Recruiting
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
NCT04928846Non Small Cell Lung Cancer
AbbVie
Phase 3
768
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Shantou, Zhanjiang
2022-03-25
Active, closed
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
NCT05317416Multiple Myeloma
Pfizer
Phase 3
854
Guangzhou, Tianjin, Wenzhou
2022-03-25
Active, closed
Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT05348577Prostate Cancer
AstraZeneca
Phase 3
1,035
Beijing, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Jiaxing
2022-03-25
Active, closed
Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)
NCT05224141Small Cell Lung Carcinoma
Merck Sharp & Dohme LLC
Phase 3
460
Hefei, Beijing, Fuzhou, Harbin, Zhengzhou, Wuhan, Changsha, Suzhou
2022-03-24
Recruiting
Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer
NCT05345860Early-stage Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
300
Beijing, Langfang
2022-03-24
Active, closed
A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer
NCT05227664Metastatic Triple-negative Breast Cancer, Locally Advanced Triple-negative Breast Cancer
Akeso
Phase 2
120
Changsha, Xiangyang
2022-03-23
Active, closed
A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
NCT05662020Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc
Phase 3
2,750
Kunming
2022-03-23
Active, closed
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
NCT05277051Neoplasms
GlaxoSmithKline
Phase 1
152
Chengdu, Jinan, Shanghai, Wuhan
2022-03-22
Recruiting
Fecal Microbiota Transplantation in Pediatric Crohn's Disease
NCT05321745Crohn Disease
Biao Zou
Not applicable
40
Wuhan
2022-03-22
Recruiting
Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
NCT05739253Aortic Stenosis, Ascending Aortic Dilatation, Bicuspid Aortic Valve
China National Center for Cardiovascular Diseases
Observational
480
Beijing
2022-03-22
Recruiting
A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
NCT05387369COVID-19
Huashan Hospital
Observational
2,000
Shanghai
2022-03-21
Recruiting
Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma
NCT06746480Advanced Intrahepatic Cholangiocarcinoma
CNBG-Virogin Biotech (Shanghai) Ltd.
Phase 2
33
Hangzhou
2022-03-19
Active, closed
A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
NCT05009069Rectal Neoplasms, Rectal Cancer
Hoffmann-La Roche
Phase 2
58
Beijing, Guangzhou, Hangzhou, Shanghai, Shenyang
2022-03-18
By invitation
A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
NCT06707922Chronic Hepatitis B
Xiamen Amoytop Biotech Co., Ltd.
Not applicable
350
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Guanzhou, Harbin, Hefei
2022-03-18
Recruiting
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NCT05219721Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia
Chunrui Li
Phase 1
18
Wuhan
2022-03-17
Recruiting
EA for BPS: An RCT and Study for Central Mechanism
NCT05279963Bladder Pain Syndrome
The Third Affiliated hospital of Zhejiang Chinese Medical University
Not applicable
84
Hangzhou
2022-03-16
Recruiting
A Study of SKB315 in Patients With Advanced Solid Tumors
NCT05367635Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
246
Tianjin
2022-03-16
Recruiting
Multicenter Cohort Study of AAV in Hunan of China
NCT05315141ANCA Associated Vasculitis
Xiangya Hospital of Central South University
Observational
500
Changsha
2022-03-16
Recruiting
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
NCT05494060Carcinoma, Gastrointestinal Diseases, Stomach Cancer, Gastroesophageal-junction Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
80
Nanjing
2022-03-16
Recruiting
Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC
NCT05856383HER2-positive Advanced Breast Cancer
Zhejiang Cancer Hospital
Observational
100
Hangzhou
2022-03-16
Active, closed
Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
NCT05248646Immunoglobulin A Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Beijing, Xiamen, Guangzhou, Shenzhen, Liuzhou, Nanning, Wuhan, Changsha
2022-03-15
Recruiting
Fingolimod for Type 2 Diabetes Mellitus
NCT05307731Diabetes Mellitus, Type 2
General Hospital of Shenyang Military Region
Phase 4
40
Shenyang
2022-03-15
Recruiting
Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients
NCT05277688Cervical Cancer
Ruijin Hospital
Phase 3
340
Shanghai
2022-03-15
Rows per page Showing 16701–16800 of 19052
Previous 166 167 168 169 170 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=168

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.